Ongoing Research to Watch in TNBC

The panel concludes by highlighting pivotal ongoing trials and investigational agents shaping the future of TNBC care. Areas of focus include next-generation ADCs, bispecific antibodies, and novel immunotherapy combinations designed to overcome resistance. Panelists also underscore the need for improved biomarker discovery, especially to identify which patients benefit most from immunotherapy or ADC-based regimens. They note that the TNBC research field is entering a dynamic phase where rational combination strategies and earlier intervention with effective agents could significantly improve patient outcomes.